{"id":"salicylic-acid-6","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation"},{"rate":null,"effect":"Erythema"},{"rate":null,"effect":"Dryness"},{"rate":null,"effect":"Peeling"},{"rate":null,"effect":"Burning sensation"}]},"_chembl":null,"_dailymed":{"setId":"41eaa88c-a980-ea4f-e063-6294a90a411a","title":"SALICYLIC ACID 6% GEL (SALICYLIC ACID) GEL [PURETEK CORPORATION]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Salicylic acid is a beta hydroxy acid (BHA) that penetrates the skin and breaks down the bonds between corneocytes in the stratum corneum, facilitating desquamation. It also has mild anti-inflammatory and antimicrobial properties. At 6% concentration, it is commonly used for topical treatment of hyperkeratotic skin conditions.","oneSentence":"Salicylic acid works as a keratolytic agent that softens and dissolves the outer layer of skin, promoting exfoliation and removal of dead skin cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T06:24:46.778Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acne vulgaris"},{"name":"Psoriasis"},{"name":"Warts"},{"name":"Calluses and corns"},{"name":"Seborrheic keratosis"}]},"trialDetails":[{"nctId":"NCT07429747","phase":"NA","title":"Performance of Reinforced 3D-Printed Versus Direct Bulk-Filled Resin Composites for Restoring Extensive Class II Cavities in Vital Molars","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Reda Abd EL Rahman","startDate":"2026-02-20","conditions":"Class II Lesions, 3D Printing, Bulk Fill","enrollment":50},{"nctId":"NCT03070886","phase":"PHASE2, PHASE3","title":"Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery","status":"COMPLETED","sponsor":"NRG Oncology","startDate":"2017-04-05","conditions":"Stage I Prostate Adenocarcinoma AJCC v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage III Prostate Adenocarcinoma AJCC v7","enrollment":612},{"nctId":"NCT05050084","phase":"PHASE3","title":"Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial","status":"RECRUITING","sponsor":"NRG Oncology","startDate":"2021-12-06","conditions":"Prostate Adenocarcinoma","enrollment":2050},{"nctId":"NCT04513717","phase":"PHASE3","title":"Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"NRG Oncology","startDate":"2021-01-21","conditions":"Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8","enrollment":2753},{"nctId":"NCT07329907","phase":"PHASE2","title":"Combination Therapy for Warts: Candida Antigen vs. Topical Keratolytic","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-12-01","conditions":"Warts, Human Papilloma Virus (HPV)","enrollment":126},{"nctId":"NCT03513770","phase":"EARLY_PHASE1","title":"Autonomic Control of the Circulation and VDR","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2019-08-14","conditions":"Venous Distension Reflex, Blood Pressure","enrollment":18},{"nctId":"NCT03678025","phase":"PHASE3","title":"Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2018-09-24","conditions":"Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer AJCC v8","enrollment":1273},{"nctId":"NCT04356326","phase":"PHASE3","title":"Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2021-02-15","conditions":"Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia, Intrauterine Growth Restriction","enrollment":500},{"nctId":"NCT05753267","phase":"PHASE2, PHASE3","title":"Fenofibrate in Ulcerative Colitis","status":"RECRUITING","sponsor":"Tanta University","startDate":"2023-02-28","conditions":"Inflammatory Bowel Diseases","enrollment":60},{"nctId":"NCT06861725","phase":"NA","title":"CARIES ARREST USING SILVER DIAMINE FLUORIDE VERSUS FISSURE SEALANT in OCCLUSAL DENTAL CARIOUS LESIONS: RANDOMIZED CONTROLLED TRIAL","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2025-04-01","conditions":"Dental Caries, Caries Arrested, Silver Diamine Fluoride","enrollment":76},{"nctId":"NCT06233019","phase":"NA","title":"Glycolic Acid Plus Salicylic Acid in Treatment of Plane Wart","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-12-01","conditions":"Plane Wart","enrollment":100},{"nctId":"NCT05151991","phase":"NA","title":"A Clinical Trial on the Failure Rates of Metallic and Ceramic Orthodontic Brackets","status":"COMPLETED","sponsor":"University of Pavia","startDate":"2021-12-09","conditions":"Dental Malocclusion","enrollment":80},{"nctId":"NCT04933331","phase":"","title":"Early Caries Lesion Management Observational Study","status":"UNKNOWN","sponsor":"CareQuest Institute for Oral Health","startDate":"2020-12-07","conditions":"Initial Caries, Arrested Dental Caries, Cavitated Caries","enrollment":744},{"nctId":"NCT05469880","phase":"NA","title":"Efficacy and Tolerance of Formula 609613 37 in Acneic Patients","status":"COMPLETED","sponsor":"Cosmetique Active International","startDate":"2009-10-21","conditions":"Acne","enrollment":100},{"nctId":"NCT02422485","phase":"PHASE1","title":"A 6 Month, Open-Label, Pilot Futility Clinical Trial of Oral Salsalate for Progressive Supranuclear Palsy","status":"COMPLETED","sponsor":"Adam Boxer","startDate":"2015-04","conditions":"Progressive Supranuclear Palsy","enrollment":10},{"nctId":"NCT04326816","phase":"NA","title":"Restorative Treatment of Severe Tooth Wear; Direct vs Indirect","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2010-11","conditions":"Tooth Wear, Dental Restoration Failure, Dental Restoration Wear","enrollment":42},{"nctId":"NCT01129440","phase":"PHASE2","title":"Glass Ionomer Sealant and Fluoride Varnish Study to Prevent Early Childhood Caries","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2011-06","conditions":"Dental Caries","enrollment":597},{"nctId":"NCT00699907","phase":"PHASE2","title":"Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer","status":"COMPLETED","sponsor":"University of Arizona","startDate":"2005-01","conditions":"Ovarian Cancer","enrollment":127},{"nctId":"NCT03029494","phase":"NA","title":"Oxidative Stress and Opiorphin in Temporomandibular Disorders","status":"UNKNOWN","sponsor":"Croatian Science Foundation","startDate":"2015-10-01","conditions":"Temporomandibular Disorders","enrollment":80},{"nctId":"NCT02338180","phase":"PHASE4","title":"Preventive and Therapeutic Proximal Sealants","status":"COMPLETED","sponsor":"Universidad de Valparaiso","startDate":"2009-03","conditions":"Dental Caries","enrollment":390},{"nctId":"NCT02717286","phase":"NA","title":"Restorative Treatment in First Molars Affected by Molar-Incisor Hypomineralization","status":"COMPLETED","sponsor":"Universidade Federal do Paraná","startDate":"2013-01","conditions":"Molar Incisor Hypomineralization","enrollment":26},{"nctId":"NCT01141153","phase":"PHASE4","title":"Anticoagulation in Stent Intervention","status":"UNKNOWN","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2010-06","conditions":"Atrial Fibrillation, Stroke","enrollment":304},{"nctId":"NCT01731756","phase":"NA","title":"Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2013-01","conditions":"Arsenical Keratosis","enrollment":50},{"nctId":"NCT01800279","phase":"NA","title":"Physiotherapy and Deontology in the Temporomandibular Joint Dysfunction in Patients With Fibromyalgia Syndrome.","status":"COMPLETED","sponsor":"Universidad de Almeria","startDate":"2013-03","conditions":"Temporomandibular Joint Dysfunction Syndrome","enrollment":70},{"nctId":"NCT01909999","phase":"NA","title":"Release of Osteogenic Markers in Immediately and Non-loaded Dental Implants","status":"COMPLETED","sponsor":"Renato Correa Viana Casarin","startDate":"2010-03","conditions":"Jaw, Edentulous","enrollment":40},{"nctId":"NCT01139749","phase":"PHASE4","title":"Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea","status":"UNKNOWN","sponsor":"Federal University of São Paulo","startDate":"2011-10","conditions":"Seborrhea, Seborrheic Dermatitis, Quality of Life","enrollment":50},{"nctId":"NCT01424332","phase":"PHASE1","title":"To Evaluate Whether Acetyl Salicylic Acid (Aspirin) and Darexaban (YM150) Interact in Their Effects","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2007-12","conditions":"Pharmacodynamic and Pharmacokinetic Interaction, Healthy Subjects","enrollment":24},{"nctId":"NCT00518141","phase":"NA","title":"Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)","status":"COMPLETED","sponsor":"Sykehuset Telemark","startDate":"2006-03","conditions":"Reproductive Techniques, Assisted","enrollment":300},{"nctId":"NCT00587496","phase":"PHASE1","title":"30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers","status":"UNKNOWN","sponsor":"National Eye Institute (NEI)","startDate":"2006-04","conditions":"Herpes Simplex","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":19,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Salicylic Acid (6%)","genericName":"Salicylic Acid (6%)","companyName":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","companyId":"bangabandhu-sheikh-mujib-medical-university-dhaka-bangladesh","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Salicylic acid works as a keratolytic agent that softens and dissolves the outer layer of skin, promoting exfoliation and removal of dead skin cells. Used for Acne vulgaris, Psoriasis, Warts.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}